Access Official Technical PDF

Share Summary:LinkedInEmail

Low-flow oxygen humidification is a recurring clinical question in the delivery of supplemental oxygen, particularly for people receiving long-term oxygen therapy (LTOT). Nasal cannulas are commonly used because they deliver oxygen through nasal prongs while allowing patients to breathe spontaneously. But oxygen is dry, and the comfort and physiological effects of delivering it without added moisture can vary. Evidence summarized in a 2020 review points to a persistent gap: routine humidification is not consistently recommended or shown to provide clear benefits for every adult receiving low-flow oxygen.

Why humidification practices differ

LTOT is generally defined as oxygen use for at least 15 hours per day over 30 days or longer. Although oxygen therapy is commonly prescribed for hypoxemia, prolonged use through a nasal cannula raises practical questions about dryness, comfort, airway secretions and adherence.

Guidance varies by region and care setting. In Europe and North America, oxygen delivered by nasal cannula is generally not humidified routinely at flows below 5 L/min. Some guidance does not recommend routine humidification for adults receiving oxygen at 4 L/min or less, while other recommendations support humidification in long-term or low-flow use. Practice can also differ for infants and pediatric patients.

The upper respiratory tract warms and humidifies inhaled gas. The review notes that higher oxygen flows can increase the cooling effect and the amount of moisture needed to condition the gas. Clinicians therefore need to consider the patient’s prescribed oxygenation needs alongside comfort and the limitations of available humidification equipment.

Low-flow oxygen humidification and bubble humidifiers

Cold bubble humidifiers are a common passive option. In these devices, oxygen passes through water in a reservoir and picks up some moisture before continuing through tubing to the patient interface. They do not require an external energy source or water supply.

However, adding a humidifier does not necessarily mean the delivered gas reaches a level of humidity considered adequate by cited guidelines. The review describes a randomized clinical trial in which cold bubble humidification did not prevent deterioration in mucociliary clearance, mucus dehydration or pulmonary function compared with dry long-term low-flow oxygen. In that study, measured absolute humidity was 21 mg/L with the bubble humidifier and 9 mg/L without humidification; neither reached the cited guideline level of 44 mg/L.

Bubble humidifiers also have operational limitations. Unheated models are described as working within a flow range of 2 to 6 L/min, with reduced humidification efficiency at higher flows. Heated bubble systems can produce condensate that may obstruct narrow-bore tubing. The review also notes that this type of humidifier is contraindicated for patients with an endotracheal tube, tracheostomy or tenacious secretions.

Airway symptoms, clearance and infection considerations

Dry or inadequately humidified gas may affect ciliary function and mucus properties, potentially impairing mucociliary clearance—the process by which the airways move mucus and trapped material. In people with chronic respiratory conditions and productive cough, changes to secretions and clearance can be clinically relevant. The review discusses evidence that heated humidification can preserve mucociliary clearance and pulmonary function, while also noting that cold bubble humidification may not provide equivalent effects.

Patient-reported symptoms do not establish a consistent advantage for humidification. Across studies summarized in the review, there was no statistically significant difference between humidified and non-humidified low-flow oxygen in reported dry nose, dry nose and throat, cough, nosebleed or chest discomfort. The authors caution that the quality of many included trials was poor, so these results should be interpreted carefully. Larger, rigorously designed studies are needed to clarify when bubble-humidified oxygen provides a meaningful benefit.

Infection control is another consideration. Reusable humidifier reservoirs can become contaminated, and the review identifies bubble humidifiers as a potential source of micro-aerosols containing bacteria. Reported contamination has included organisms such as Pseudomonas and Staphylococcus aureus. Reusable equipment therefore requires attention to cleaning and water-management practices. The review also cites findings that disposable humidifiers may remain sterile for specified periods, but those findings do not remove the need to follow applicable device instructions and clinical protocols.

Comfort and adherence to long-term oxygen therapy

A prescribed oxygen regimen only helps when it is used as directed. The review describes adherence as difficult to assess: patients may overestimate how long they use oxygen, and use during sleep or exercise can complicate estimates of daytime use. Discomfort, inconvenience and embarrassment are among the factors associated with poor adherence.

Equipment and mobility also matter. Patients who need higher flows may face limitations with portable oxygen options. Cylinders can be physically burdensome, and the review notes that access to liquid oxygen has declined in some parts of the United States, potentially leaving some patients with fewer practical mobility options. These challenges are distinct from humidification itself, but they form part of the broader delivery and adherence problem.

Practical implications for oxygen delivery

The evidence does not support a single humidification approach for every adult receiving low-flow oxygen. Instead, care teams should weigh the prescribed flow, patient symptoms, equipment limitations, infection-control requirements and the purpose of therapy. A bubble humidifier may be commonly available, but its presence should not be assumed to deliver guideline-level humidity or to prevent airway symptoms.

  • Confirm the clinical context: Apply guidance appropriate to the patient population, care setting and prescribed oxygen flow.
  • Consider device limits: Account for flow range, condensate risks, tubing and interface, and any contraindications.
  • Assess the patient’s experience: Monitor comfort and symptoms rather than assuming humidification will resolve dryness.
  • Include infection prevention: Follow cleaning, replacement and handling procedures for reusable or disposable equipment.
  • Address adherence barriers: Consider mobility, convenience and the patient’s ability to use the prescribed oxygen system in daily life.

Conclusion

Low-flow oxygen humidification remains an area where practice varies and the evidence is not definitive. Cold bubble humidifiers are widely used, but studies summarized in the review raise questions about their ability to provide adequate humidity or protect mucociliary clearance, while reservoir contamination is a relevant operational concern. For clinicians and respiratory-care teams, the practical priority is an individualized approach: match oxygen delivery to clinical need, understand equipment limitations, monitor patient response and follow infection-control procedures. Better-quality trials are still needed to establish which patients are most likely to benefit from humidification.

Access Official Technical PDF

About The Author